ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 173516 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 173516; 2) Community: the network communities that were significantly associated with the response to NSC 173516; 3) Molecule: the relationships between components within communities and NSC 173516; 4) MDR: the compounds that were significantly associated with the NSC 173516.

NSC Compound Enrichment Correlation
NSC 749245 N-(3-{(2E)-3-[4-(diethylamino)phenyl]prop-2-enoyl}phenyl)methanesulfonamide 0.0454469012959173 0.30239891
NSC 749518 1-[(2Z)-3-amino-3-phenylprop-2-enoyl]-3-phenyl-1H-pyrazol-5-amine 0.0454469012959173 0.419769
NSC 752892 N-[4-(4-Benzoylamino-pyrrolo[3,2-c]pyridin-1-yl)-phenyl]-4-(4-morpholin-4-yl)-3-trifluoromethylbenzamide 0.0454469012959173 0.60720885
NSC 75520 Thymidine, .alpha.,.alpha.,.alpha.-trifluoro- (8CI 9CI) 0.0454469012959173 0.44122026
NSC 758845 Null 0.0454469012959173 0.38801516
NSC 77039 Null 0.0454469012959173 0.39256077
NSC 94945 Questiomycin A 0.0454469012959173 0.20119298
NSC 382032 Null 1.12445458734372e-005 0.57859379
NSC 133072 Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) 1.80303315873685e-005 0.76558917
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 2.16417361041572e-005 0.80616963
Total:87  Current:86    [First] [Prev] [Next] [Last]